Press Resease

Live Cell Encapsulation Market - Global Industry Analysis

Live Cell Encapsulation Market- by Technique (Liquid Jet, Dripping, Coaxial airflow), by Polymer Type (Silica, Alginate, Cellulose sulfate, Chitosan), by Application (Drug delivery, Probiotics, Research, Transplant) - Global Industry Perspective Comprehensive Analysis and Forecast, 2020 - 2026

Published Date: 26-Nov-2020 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4187 Status : Published

According to the report, global demand for Live Cell Encapsulation market was valued at approximately USD 259.5 million in 2019, and is expected to generate revenue of around USD 325.7 million by end of 2026, growing at a CAGR of around 3.3 % between 2020 and 2026.

Description

According to the report, global demand for Live Cell Encapsulation market was valued at approximately USD 259.5 million in 2019, and is expected to generate revenue of around USD 325.7 million by end of 2026, growing at a CAGR of around 3.3 % between 2020 and 2026.

Global Live Cell Encapsulation Market: Overview

Cell encapsulation technique comprises of restricting cells within polymeric semipermeable membrane for helping in two-way molecule diffusion including oxygen influx and outward diffusing of waste items. Cell microencapsulation technology requires the immobilization of cells inside a semi-permeable polymeric membrane that enables molecules such as oxygen, nutrients, growth factors, etc., necessary for cell metabolism and the external diffusion of waste products and therapeutic proteins, to be bidirectionally diffused.

Global Live Cell Encapsulation Market: Growth Factors

Massive funding of public as well as private enterprises for promoting product development and encouraging research activities for increasing the efficiency of clinical trials in cell technology will propel the market trends. Apart from this, the growing awareness among the population about the major role played by encapsulated cells in managing the chronic ailments will further spur the growth graph of the live cell encapsulation business. Nonetheless, the restricted access to raw materials of high-quality and large-scale acceptance of alternate mode of treatments are projected to inhibit the upsurge of live cell encapsulation market in the years ahead. Moreover, an increase in the utilization of cell encapsulation methods by the healthcare service providers and medical experts are one of the few factors supplementing the surge of the live cell encapsulation industry.

The industry growth is also influenced by the rising occurrence of target disorders, massive use of new drug delivery systems for treatment of the chronic ailments, and technological breakthroughs. Large scale application of the technology in probiotics, drug delivery, and cell transplantation will scape up the business scope.

Global Live Cell Encapsulation Market: Segmentation

The live cell encapsulation market can be segmented into technique, application, and polymer type. Based on the technique, the market is classified into a liquid jet, dripping, and coaxial airflow. Application wise, the live cell encapsulation industry is divided drug delivery, probiotics, research, and transplant. On the basis of polymer type, the live cell encapsulation market is segregated into silica, alginate, cellulose sulfate, and chitosan.

Global Live Cell Encapsulation Market: Regional Analysis

Based on the region, the live cell encapsulation market can be divided into five main regions: Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa. North America live cell encapsulation market is projected to experience profitable growth in the near future. The regional market expansion can be accredited to rise in the public sector as well as private sector funding of research activities related to living cell encapsulation sector in countries such as Canada and the U.S. Additionally, the presence of key players will steer the live cell encapsulation industry surge in North America.

Large-scale research activities in the biotechnology sector witnessed in countries such as Germany and the UK will ensure massive business growth in the European region. The growing awareness about healthcare and need for devising new methods of treating chronic diseases in countries such as India, Bangladesh, Thailand, Indonesia, Pakistan, Sri Lanka, and China will further embellish the growth of Asia Pacific market in the foreseeable future.

Global Live Cell Encapsulation Market: Competitive Players

Few of the main participants in live cell encapsulation market include BioTime, Inc., Neurotech Pharmaceuticals, Inc., Lycored, Sigilon Therapeutics, Inc., Evonik Industries, Blacktrace Holdings Ltd., Balchem Corporation, Reed Pacific Pty Ltd., Living Cell Technologies Ltd., Merck KGAA, Encapsys, LLC, BÜCHI Labortechnik AG, Sernova Corporation, and MiKroCaps.

The report segments the Global Live Cell Encapsulation market as follows:

Global Live Cell Encapsulation Market: Technique Segment Analysis

  • Liquid Jet
  • Dripping
  • Coaxial airflow

Global Live Cell Encapsulation Market: Polymer Type Segment Analysis

  • Silica
  • Alginate
  • Cellulose sulfate
  • Chitosan

Global Live Cell Encapsulation Market: Application Segment Analysis

  • Drug delivery
  • Probiotics
  • Research
  • Transplant

Global Live Cell Encapsulation Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Live Cell Encapsulation Market, 2016 - 2026, (USD Million)
    • 2.2. Live Cell Encapsulation Market: Snapshot
  • Chapter 3. Global Live Cell Encapsulation Market – Industry Analysis
    • 3.1. Live Cell Encapsulation Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Target Diseases
      • 3.2.2. Focus on Novel Drug Delivery Systems for Disease Treatment
    • 3.3. Restraints
      • 3.3.1. High Product Manufacturing Costs
    • 3.4. Opportunity
      • 3.4.1. Rising Research Activity
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Technique segment
      • 3.6.2. Market attractiveness analysis by Pulymer Type segment
      • 3.6.3. Market attractiveness analysis by Application segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global Live Cell Encapsulation Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Live Cell Encapsulation market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Disease category launches
      • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Live Cell Encapsulation Market – Technique Segment Analysis
    • 5.1. Global Live Cell Encapsulation market overview: by Technique
      • 5.1.1. Global Live Cell Encapsulation market revenue share, by Technique, 2019 and 2026
    • 5.2. Liquid Jet
      • 5.2.1. Global Live Cell Encapsulation market by Liquid Jet, 2016-2026 (USD Million)
    • 5.3. Dripping
      • 5.3.1. Global Live Cell Encapsulation market by Dripping, 2016-2026 (USD Million)
    • 5.4. Coaxial airflow
      • 5.4.1. Global Live Cell Encapsulation market by Coaxial airflow, 2016-2026 (USD Million)
  • 6. Global Live Cell Encapsulation Market – Pulymer Type Segment Analysis
    • 6.1. Global Live Cell Encapsulation market overview: by Pulymer Type
      • 6.1.1. Global Live Cell Encapsulation market revenue share, by Pulymer Type, 2019 and 2026
    • 6.2. Silica
      • 6.2.1. Global Live Cell Encapsulation market by Silica, 2016-2026 (USD Million)
    • 6.3. Alginate
      • 6.3.1. Global Live Cell Encapsulation market by Alginate, 2016-2026 (USD Million)
    • 6.4. Cellulose sulfate
      • 6.4.1. Global Live Cell Encapsulation market by Cellulose sulfate, 2016-2026 (USD Million)
    • 6.5. Chitosan
      • 6.5.1. Global Live Cell Encapsulation market by Chitosan, 2016-2026 (USD Million)
  • Chapter 7. Global Live Cell Encapsulation Market – Application Segment Analysis
    • 7.1. Global Live Cell Encapsulation market overview: by Application
      • 7.1.1. Global Live Cell Encapsulation market revenue share, by Application, 2019 and 2026
    • 7.2. Drug delivery
      • 7.2.1. Global Live Cell Encapsulation market by Drug delivery, 2016-2026 (USD Million)
    • 7.3. Probiotics
      • 7.3.1. Global Live Cell Encapsulation market by Probiotics, 2016-2026 (USD Million)
    • 7.4. Research
      • 7.4.1. Global Live Cell Encapsulation market by Research, 2016-2026 (USD Million)
    • 7.5. Transplant
      • 7.5.1. Global Live Cell Encapsulation market by Transplant, 2016-2026 (USD Million)
  • Chapter 8. Global Live Cell Encapsulation Market - Regional Analysis
    • 8.1. Global Live Cell Encapsulation market overview: by region
      • 8.1.1. Global Live Cell Encapsulation market revenue share, by region, 2019 and 2026
    • 8.2. North America
      • 8.2.1. North America Live Cell Encapsulation market, by country, 2016-2026 (USD Million)
      • 8.2.2. North America Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
      • 8.2.3. North America Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
      • 8.2.4. North America Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.2.5.2. The U.S. Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.2.5.3. The U.S. Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.2.6.2. Rest of North America Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.2.6.3. Rest of North America Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Live Cell Encapsulation market, by country, 2016-2026 (USD Million)
      • 8.3.2. Europe Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
      • 8.3.3. Europe Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
      • 8.3.4. Europe Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.3.5. U.K.
        • 8.3.5.1. U.K. Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.3.5.2. U.K. Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.3.5.3. U.K. Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.3.6.2. France Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.3.6.3. France Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.3.7.2. Germany Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.3.7.3. Germany Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.3.8.2. Rest of Europe Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.3.8.3. Rest of Europe Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Live Cell Encapsulation market, by country, 2016-2026 (USD Million)
      • 8.4.2. Asia Pacific Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
      • 8.4.3. Asia Pacific Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
      • 8.4.4. Asia Pacific Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.4.5.2. China Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.4.5.3. China Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.4.6.2. Japan Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.4.6.3. Japan Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.4.7.2. India Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.4.7.3. India Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Live Cell Encapsulation market, by country, 2016-2026 (USD Million)
      • 8.5.2. Latin America Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
      • 8.5.3. Latin America Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
      • 8.5.4. Latin America Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.5.5.2. Brazil Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.5.5.3. Brazil Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
        • 8.5.6.2. Rest of Latin America Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
        • 8.5.6.3. Rest of Latin America Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa Live Cell Encapsulation market, 2016-2026 (USD Million)
      • 8.6.2. Middle East & Africa Live Cell Encapsulation market revenue, by Technique, 2016-2026 (USD Million)
      • 8.6.3. Middle East & Africa Live Cell Encapsulation market revenue, by Pulymer Type, 2016-2026 (USD Million)
      • 8.6.4. Middle East & Africa Live Cell Encapsulation market revenue, by Application, 2016-2026 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. BioTime, Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfulio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Neurotech Pharmaceuticals, Inc
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfulio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Lycored
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfulio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Sigilon Therapeutics, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfulio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Evonik Industries
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfulio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Blacktrace Huldings Ltd.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfulio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Balchem Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfulio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Reed Pacific Pty Ltd
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfulio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Living Cell Technulogies Ltd.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfulio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Merck KGAA
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfulio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social